Pierre Fabre Laboratories to accelerate their development in onco-hematology by acquiring the license for a breakthrough T-cell immunotherapy in North America thailand-business-news.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thailand-business-news.com Daily Mail and Mail on Sunday newspapers.
Pierre Fabre Laboratories to License Commercialization Rights to Tab-cel®, including Regulatory, Manufacturing and Development Activities, in the United States and All Remaining Markets
Atara to.
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) was the recipient of a significant increase in short interest in October. As of October 15th, there was short interest totalling 12,270,000 shares, an increase of 6.3% from the September 30th total of 11,540,000 shares. Based on an average daily trading volume, of 1,170,000 shares, the days-to-cover […]
StockNews.com initiated coverage on shares of Atara Biotherapeutics (NASDAQ:ATRA – Free Report) in a research note published on Thursday morning. The firm issued a sell rating on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and set a $28.00 price target on shares of Atara Biotherapeutics in a research note on Tuesday, […]